Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06432881 · ClinicalTrials.gov registry record · NA

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

A NA study of Hypoxemia, sponsored by Masimo Corporation.

Recruiting
Registry status
NA
Development phase
152
Enrollment target
1
Study location

NCT06432881 is a NA study of Hypoxemia that is actively recruiting participants, run by Masimo Corporation. The registered enrollment target is 152 participants, below the 480-participant average among 10 other Hypoxemia trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06432881, a NA study of Hypoxemia, is actively recruiting participants, sponsored by Masimo Corporation.

RECRUITING
Registry status
NA
Development phase
152 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate the performance of Masimo RD SET® SpO2 sensors in subjects with light and dark skin pigmentation in the intensive care therapeutic area.

Conditions Studied

Interventions

  • DEVICE RD SET Sensor

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2024-01-08
Est. Completion 2026-03-01
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT06432881

The ClinicalTrials.gov registry entry for NCT06432881 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 480-participant average among 10 other Hypoxemia trials with a reported enrollment target (68% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxemia appearing as the primary indexed condition, and to 1 intervention - of which RD SET Sensor is the first listed.

NCT06432881 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT06432881 about?

NCT06432881 is a clinical study titled "Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)". The objective of this study is to evaluate the performance of Masimo RD SET® SpO2 sensors in subjects with light and dark skin pigmentation in the intensive care therapeutic area.

What is the current status of trial NCT06432881?

This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2024-01-08. Estimated completion is 2026-03-01.

What conditions does trial NCT06432881 study?

This clinical trial studies the following conditions: Hypoxemia.

What interventions are being tested in trial NCT06432881?

The interventions under investigation include: RD SET Sensor (DEVICE).

Who is sponsoring clinical trial NCT06432881?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06432881 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.